Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosis

PHASE4CompletedINTERVENTIONAL
Enrollment

606

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Liver Cirrhosis
Interventions
DRUG

Entecavir

anti-viral therapy

DRUG

Thymosin-α

anti-viral and antitherapy

Trial Locations (21)

30001

The First Hospital of Shanxi Medical University, Taiyuan

50021

Shijiazhuang Fifth Hospital, Shijiazhuang

100015

Beijing Ditan Hospital, Capital Medical University, Beijing

100034

Peking University First Hospital, Beijing

100039

302 Military Hospital Of China, Beijing

100050

Beijing Friendship Hospital, Capital Medical University, Beijing

Beijing Tiantan Hospital, Capital Medical University, Beijing

Peking University People's Hospital, Beijing

100069

Beijing YouAn Hospital, Capital Medical University, Beijing

100730

Peking Union Medical College Hospital, Beijing

100871

PeKing University, Beijing

133000

The Affiliated Hospital of Yanbian University, Yanbian

200032

RenjiHospital,Shanghai Jiao Tong University,School of Medicine, Shanghai

200040

Huashan Hospital FuDan University, Shanghai

Zhongshan Hospital Fudan University, Shanghai

200080

Shanghai First People's Hospital, Shanghai

201508

Shanghai Public Health Clinical Center, Shanghai

300030

Tongji Hospital, Tongji Medical College ,Huazhong University of Science &Technology, Wuhan

300162

The Hospital Affiliated to Logistics University of Chinese People's Armed Police Force, Tianjin

310016

Sir Run Run Shaw Hospital,School of Medicine,Zhejiang University, Hangzhou

510515

NanfangHospital,Southern Medical University, Guangzhou

All Listed Sponsors
collaborator

Peking University People's Hospital

OTHER

collaborator

RenJi Hospital

OTHER

collaborator

Peking University

OTHER

collaborator

Shanghai Zhongshan Hospital

OTHER

collaborator

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

OTHER

collaborator

Shanghai Public Health Clinical Center

OTHER_GOV

collaborator

Nanfang Hospital, Southern Medical University

OTHER

collaborator

Sir Run Run Shaw Hospital

OTHER

collaborator

Beijing YouAn Hospital

OTHER

collaborator

Peking University First Hospital

OTHER

collaborator

Beijing 302 Hospital

OTHER

collaborator

Peking Union Medical College Hospital

OTHER

collaborator

Beijing Ditan Hospital

OTHER

collaborator

Beijing Tiantan Hospital

OTHER

collaborator

Huashan Hospital

OTHER

collaborator

Tongji Hospital

OTHER

collaborator

Tang-Du Hospital

OTHER

collaborator

Fifth Hospital of Shijiazhuang City

OTHER

collaborator

Logistics University of Chinese People's Armed Police Forces

OTHER

collaborator

The First Affiliated Hospital of Shanxi Medical University

OTHER

collaborator

The Affiliated Hospital of Yanbian University

OTHER

lead

Beijing Friendship Hospital

OTHER

NCT01943617 - Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosis | Biotech Hunter | Biotech Hunter